1Hussein MR,Roggero E,Sudilovsky EC,et al.Alterations of mismatch repair protein expression in benign melanocytic nevi,melanocytic dysplastic nevi,and cutaneous malignant melanomas.Am J Dermatopathol,2001,23:308-314.
2Lynch HT,de la Chapelle A.Genetic susceptibility to non-polyposis colorectal cancer.J Med Genet,1999,36:801-818.
3Marcus VA,Madlensky L,Gryfe R,et al.Immunohistochemistry for hMLH1 and hMSH2:a practical test for DNA mismatch repair-deficient tumors.Am J Surg Pathol,1999,23:1248-1255.
4Karran P.Appropriate partners make good matches.Science,1995,268(5219):1857-1858.
5Karran P.Microsatellite instability and DNA mismatch repair in human cancer.Semin Cancer Biol,1996,7:15-24.
6Korabiowska M,Brinck U,Dengler H,et al.Analysis of the DNA mismatch repair proteins expression in malignant melanomas.Anticancer Res,2000,20:4499-4505.
7Korabiowska M,Viehover M,Schlott T,et al.Relationship between DNA ploidy-related parameters and the deletions in mismatch repair genes MLHl and MSH2 in lentigo maligna and malignant melanomas.Arch Dermatol Res,2001,293:219-225.
6Munoz N,Bosch FX,de Sanjose S,et al. Epidemiologic classification of human papillomavims types associated with cervical cancer[ J]. N Engl J Med,2003,348(6) :518 -527..
7Carter JJ, Madeleine MM, Shera K, et al. Human papillomavirusl6 and 18 L1 serology compared across anogenital cancer sites [ J ]. Cancer Res ,2001,61 (5) : 1934 - 1940.
8Zheng S, Adachi A, Shimizu M. Human papillomaviruses of the nmcosal type are present in some case of extragenital Bowen disease [ J ]. British Journal of Dermatology,2005,152 (6) : 1243 - 1247.
9Lampert A,Pauwels C, Duboucher C, et al. Detection of human papillo- mavirus in cutaneous extragenital Bowen's disease in immunocompetent patients[ J]. Ann Dermatol Venereo1,2000,127 ( 1 ) :40.
10Iyer RR, Plueienni KA, Burdett V, et al. DNA mismatch repair: functions and mechanisms[ J]. Chem Rev,2006,106(2) :302 -323.